AstraZeneca (AZN) has disclosed a new risk, in the Economy & Political Environment category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AstraZeneca faces significant risks from geopolitical and macroeconomic volatility due to its operations in over 100 countries. These risks include potential disruptions from global economic downturns, high inflation, and geopolitical tensions that could lead to increased trade controls and tariffs. Such factors may adversely affect AstraZeneca’s financial performance by increasing costs, reducing revenues, and straining supplier relationships. Additionally, ineffective measures to mitigate inflation could result in substantial additional costs, further pressuring the company’s margins and profitability.
The average AZN stock price target is $87.34, implying 24.04% upside potential.
To learn more about AstraZeneca’s risk factors, click here.